Integrated BioPharma, Inc. (INBP)

Market Cap	5.19M -36.4%
Revenue (ttm)	48.25M -8.8%
Net Income	-1.65M
EPS	-0.05
Shares Out	31.06M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	32,001
Open	0.1900
Previous Close	0.1800
Day's Range	0.1670 - 0.1900
52-Week Range	0.1375 - 0.4199
Beta	0.38
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 24, 2026

About Integrated BioPharma

Integrated BioPharma, Inc., together with its subsidiaries, engages in the manufacturing, distributing, marketing and sale of vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. The company operates through two segments, Contract Manufacturing and Other Business Lines. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment provides wareho...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 1980
• Employees: 153
• Stock Exchange: OTCMKTS
• Ticker Symbol: INBP

Financial Performance

In fiscal year 2025, Integrated BioPharma's revenue was $54.35 million, an increase of 8.02% compared to the previous year's $50.32 million. Earnings were $808,000, an increase of 621.43%.

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 25, 2026

Data Sources Report a data error